Loading…
Pharmaceutical Market Access Act of 2003
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
91pct
195d open
vs 3,018 other S bills in the 108th — cohort avg 48d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2004 · year_end · Pharmacy
1. H.R. 1, S. 1, Medicare Prescription Drug Legislation. 2. H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · mid_year · Pharmacy
H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · mid_year · Pharmacy
1. S. 1113, Improved access to osteoporosis testing act of 2003. 2. H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · mid_year · Pharmacy
H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| SD |